Free Trial
→ He Called NVIDIA at $1.10 – Now He Says, “SELL” (From The Oxford Club) (Ad)tc pixel Free PBMWW Stock Alerts

Psyence Biomedical (PBMWW) Competitors

$0.04 -0.01 (-20.00%)
As of 06/9/2026 03:31 PM Eastern
Compare

PBMWW vs. AIMDW, ALVOW, ARAV, ACABW, and BFRIW

Should you buy Psyence Biomedical stock or one of its competitors? MarketBeat compares Psyence Biomedical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Psyence Biomedical include Ainos (AIMDW), Alvotech (ALVOW), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), and Biofrontera (BFRIW). These companies are all part of the "pharmaceutical products" industry.

How does Psyence Biomedical compare to Ainos?

Psyence Biomedical (NASDAQ:PBMWW) and Ainos (NASDAQ:AIMDW) are both pharmaceutical products companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, profitability, valuation, dividends, earnings, analyst recommendations, institutional ownership and risk.

Company Net Margins Return on Equity Return on Assets
Psyence BiomedicalN/A N/A N/A
Ainos N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Psyence BiomedicalN/AN/AN/AN/AN/A
Ainos$18.11KN/AN/AN/AN/A

In the previous week, Ainos had 1 more articles in the media than Psyence Biomedical. MarketBeat recorded 2 mentions for Ainos and 1 mentions for Psyence Biomedical. Psyence Biomedical's average media sentiment score of 1.89 beat Ainos' score of 0.93 indicating that Psyence Biomedical is being referred to more favorably in the media.

Company Overall Sentiment
Psyence Biomedical Very Positive
Ainos Positive

Summary

Ainos beats Psyence Biomedical on 2 of the 3 factors compared between the two stocks.

How does Psyence Biomedical compare to Alvotech?

Alvotech (NASDAQ:ALVOW) and Psyence Biomedical (NASDAQ:PBMWW) are both pharmaceutical products companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, risk, valuation, profitability, earnings, institutional ownership, dividends and media sentiment.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alvotech$586.32MN/AN/AN/AN/A
Psyence BiomedicalN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
AlvotechN/A N/A N/A
Psyence Biomedical N/A N/A N/A

In the previous week, Alvotech and Alvotech both had 1 articles in the media. Alvotech's average media sentiment score of 1.89 equaled Psyence Biomedical'saverage media sentiment score.

Company Overall Sentiment
Alvotech Very Positive
Psyence Biomedical Very Positive

Summary

Alvotech beats Psyence Biomedical on 1 of the 1 factors compared between the two stocks.

How does Psyence Biomedical compare to Aravive?

Aravive (NASDAQ:ARAV) and Psyence Biomedical (NASDAQ:PBMWW) are both pharmaceutical products companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, risk, valuation, profitability, earnings, institutional ownership, dividends and media sentiment.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AraviveN/AN/AN/A-$0.90N/A
Psyence BiomedicalN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
AraviveN/A N/A N/A
Psyence Biomedical N/A N/A N/A

35.8% of Aravive shares are held by institutional investors. 60.4% of Aravive shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, Psyence Biomedical had 1 more articles in the media than Aravive. MarketBeat recorded 1 mentions for Psyence Biomedical and 0 mentions for Aravive. Psyence Biomedical's average media sentiment score of 1.89 beat Aravive's score of 0.00 indicating that Psyence Biomedical is being referred to more favorably in the news media.

Company Overall Sentiment
Aravive Neutral
Psyence Biomedical Very Positive

Summary

Aravive and Psyence Biomedical tied by winning 2 of the 4 factors compared between the two stocks.

How does Psyence Biomedical compare to Atlantic Coastal Acquisition Corp. II?

Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) and Psyence Biomedical (NASDAQ:PBMWW) are both pharmaceutical products companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, profitability, institutional ownership, media sentiment, analyst recommendations, valuation and risk.

Company Net Margins Return on Equity Return on Assets
Atlantic Coastal Acquisition Corp. IIN/A N/A N/A
Psyence Biomedical N/A N/A N/A

In the previous week, Psyence Biomedical had 1 more articles in the media than Atlantic Coastal Acquisition Corp. II. MarketBeat recorded 1 mentions for Psyence Biomedical and 0 mentions for Atlantic Coastal Acquisition Corp. II. Psyence Biomedical's average media sentiment score of 1.89 beat Atlantic Coastal Acquisition Corp. II's score of 0.00 indicating that Psyence Biomedical is being referred to more favorably in the news media.

Company Overall Sentiment
Atlantic Coastal Acquisition Corp. II Neutral
Psyence Biomedical Very Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Atlantic Coastal Acquisition Corp. IIN/AN/AN/AN/AN/A
Psyence BiomedicalN/AN/AN/AN/AN/A

Summary

Psyence Biomedical beats Atlantic Coastal Acquisition Corp. II on 2 of the 2 factors compared between the two stocks.

How does Psyence Biomedical compare to Biofrontera?

Biofrontera (NASDAQ:BFRIW) and Psyence Biomedical (NASDAQ:PBMWW) are both pharmaceutical products companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, valuation, dividends, analyst recommendations, earnings, profitability and risk.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Biofrontera$43.20MN/AN/AN/AN/A
Psyence BiomedicalN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
BiofronteraN/A N/A N/A
Psyence Biomedical N/A N/A N/A

In the previous week, Biofrontera and Biofrontera both had 1 articles in the media. Psyence Biomedical's average media sentiment score of 1.89 beat Biofrontera's score of 1.87 indicating that Psyence Biomedical is being referred to more favorably in the news media.

Company Overall Sentiment
Biofrontera Very Positive
Psyence Biomedical Very Positive

Summary

Biofrontera and Psyence Biomedical tied by winning 1 of the 2 factors compared between the two stocks.

Get Psyence Biomedical News Delivered to You Automatically

Sign up to receive the latest news and ratings for PBMWW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PBMWW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PBMWW vs. The Competition

Export
MetricPsyence BiomedicalPharmaceutical Preparations IndustryManufacturing SectorNASDAQ Exchange
Market CapN/A$958.36M$4.87B$12.06B
Dividend YieldN/A4.84%9.42%5.55%
P/E RatioN/A1.4621.7423.76
Price / SalesN/A127.56173.06105.22
Price / CashN/A20.0643.4056.09
Price / BookN/A7.9028.966.72
Net IncomeN/A-$4.82M$118.48M$337.35M
7 Day PerformanceN/A-1.57%-2.62%-1.21%
1 Month PerformanceN/A3.80%-0.10%1.41%
1 Year PerformanceN/A96.26%12.07%23.64%

Psyence Biomedical Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PBMWW
Psyence Biomedical
N/A$0.04
-20.0%		N/A+123.5%$0.00N/AN/AN/A
AIMDW
Ainos
N/A$0.11
-0.3%		N/A+32.4%$0.00$18.11KN/A40
ALVOW
Alvotech
N/A$0.24
-7.7%		N/A-88.5%$0.00$586.32MN/A4
ARAV
Aravive
N/A$0.04
flat		N/AN/A$0.00N/AN/A20
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.00
+13.6%		N/AN/A$0.00N/AN/A15

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:PBMWW) was last updated on 6/10/2026 by MarketBeat.com Staff.
From Our Partners
He Called NVIDIA at $1.10 – Now He Says, “SELL”
The analyst who called NVIDIA at $1.10 now says sell. According to Alexander Green, Chief Investment Strategis...
The Oxford Club | Sponsoredtc pixel
Your name isn't on our protected list yet
I checked our download records for "The Big Beautiful Bubble Report" and didn't see your name. That concern...
American Alternative | Sponsoredtc pixel
I was right about SpaceX
Jeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,0...
Brownstone Research | Sponsoredtc pixel
The REAL Reason Trump is Invading Iran
For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Be...
Banyan Hill Publishing | Sponsoredtc pixel
Stranded On The Flood Plains of History
The petrodollar arrangement that Kissinger brokered in 1974 officially expired in June 2024. China has slashed...
Porter & Company | Sponsoredtc pixel
One hidden supplier shipped 5 billion parts to SpaceX
Most investors are focused on the historic $1.75 trillion SpaceX IPO expected around June 30. But there's a le...
Weiss Ratings | Sponsoredtc pixel
Trump Is Eyeing the Biggest Monetary Shift Since Nixon
On August 15, 1971, Nixon ended the Bretton Woods agreement and untethered the dollar from gold. Since that ni...
Americas Gold Company | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel